Trial Profile
Intraoperative Imaging of Pulmonary Nodules by OTL38
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jul 2022
Price :
$35
*
At a glance
- Drugs Folate-fluorescein isothiocyanate conjugate (Primary)
- Indications Lung cancer
- Focus Diagnostic use
- 27 Jun 2022 Status changed from recruiting to completed.
- 07 Jan 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
- 07 Jan 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2022.